🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Blue Light for Donor Site Healing in Burn Patients

RecruitingNAAges 18 Years - anyAllAUSL Romagna Rimini
NCT07453927 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The goal of this clinical trial is to learn whether blue light (BL) photobiomodulation can improve the healing of donor site (DS) wounds in patients with burn injuries who are treated surgically. This study will investigate whether adding BL therapy to the usual treatment can improve healing and patient outcomes in adult patients with intermediate and deep burns. The main questions it aims to answer are: * Does the use of BL therapy combined with standard treatment reduce the healing time of DS compared with standard treatment alone? * Does BL therapy improve wound conditions, reduce pain, and decrease signs of infection during the healing process? * Is BL therapy safe and well tolerated when applied to DS? * Does the treatment improve the long-term quality of the scar after healing? Researchers will compare DS areas treated with standard care alone to DS areas treated with standard c

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients with intermediate-deep burns with Total Body Surface Area (TBSA) \> 10% requiring surgical treatment with escharectomy, presenting at least two Donor Site. * Patients over 18 years of age; * Patients who have signed the informed Consent Form (ICF) and understood the purpose of the study, or, if unable to give consent personally due to their condition, their legal guardian. Exclusion Criteria: * Intermediate-deep burns TBSA \< 10% or superficial burns; * Patients under the age of 18; * Patients who are participating in other clinical trials with drugs or medical devices; * Patients with neoplasms or other conditions requiring the use of cytostatic or immunosuppressive drugs; * Patients with conditions that induce skin photosensitivity; * Pregnant or breastfeeding women; * Patients or relatives who are unable to understand the purposes of the trial;
💊

What it tests

  • Photobiomodulation with blue light
📍

Where

1 site
U.O. Centro Grandi Ustionati - Osp. Maurizio Bufalini
Cesena, Italy
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy